-
Views
-
Cite
Cite
Jeffrey Chang, Kathryn A. Martin, Robert A. Vigersky, The Hormone Foundation’s Patient Guide to the Evaluation and Treatment of Hirsutism in Premenopausal Women, The Journal of Clinical Endocrinology & Metabolism, Volume 93, Issue 4, 1 April 2008, Pages E1–E2, https://doi.org/10.1210/jcem.93.4.9996
Close - Share Icon Share
Extract
Why were the guidelines written?
This patient guide is based on The Endocrine Society’s Clinical Guidelines written to help physicians who are evaluating and treating hirsutism in premenopausal women. Hirsutism refers to excessive growth of terminal hair (the kind of hair that grows on your head) in areas where women typically grow fine (“peach fuzz”) hair. The distribution of hair follows a male pattern, appearing on the face, back, chest, etc. Hirsutism can be mild, moderate, or severe.
Hirsutism can have a major impact on a woman’s sense of well-being. Even isolated, mild hirsutism can be emotionally distressing to some woman. Any woman who is troubled by hirsutism should not hesitate to ask her doctor about treatment options. The Clinical Guidelines make recommendations about those treatment options.
How were the guidelines developed?
The Clinical Guidelines were developed after an extensive review of the best research studies related to the evaluation and treatment of hirsutism in premenopausal women. An international expert panel of The Endocrine Society examined studies that were published in “peer-reviewed” medical journals (that is, studies that were evaluated by other scientists). The panel’s “recommendations” and “suggestions” were reviewed and approved by several committees and, finally, by the general membership of The Endocrine Society. No funding for the guidelines came from any pharmaceutical or medical device company.
